17-beta-hydroxy-7 alpha-methyl-androst-5-en-3-one has been researched along with contraceptives, postcoital in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benson, HD; Grunwell, JF; Johnston, JO; Petrow, V | 1 |
| Lau, IF; Saksena, Sk; Salmonsen, R | 1 |
2 other study(ies) available for 17-beta-hydroxy-7 alpha-methyl-androst-5-en-3-one and contraceptives, postcoital
| Article | Year |
|---|---|
Endocrine properties of RMI 12,936, an antiprogestational steroid.
Topics: Androstenols; Animals; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Cricetinae; Estradiol; Female; Genitalia, Female; Genitalia, Male; Gonadotropins; Male; Pregnancy; Progesterone; Rabbits; Random Allocation; Rats; Rats, Inbred Strains; Uterus; Vaginal Smears | 1983 |
Effects of 17 beta-hydroxy-7 alpha-methylandrost-5-en-3-one on early pregnancy in the rat.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Androstenols; Animals; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Estrus; Female; Pregnancy; Progesterone; Rats | 1981 |